Congratulations to NASPGHAN Elected Leaders and especially to Vicky Ng (who I met while completing my fellowship in Cincinnati).

Briefly noted:
RS Choung et al. Clin Gastroenterol Hepatol 2022; 20(9):1977-1985. Collagenous Gastritis: Characteristics and Response to Topical Budesonide
This was an open-label, retrospective study with 64 patients with collagenous gastritis (CG) (50 adults, 14 children). Budesonide was administered in 2 formulations: open-capsule budesonide or compounded immediate-release budesonide capsule. Key finding: Of the patients treated with topically targeted budesonide (TTB), 89% had a clinical response (42% complete, 46% partial), and 88% had a histologic response (53% complete, 33% partial).
Related blog posts:
